Farther Finance Advisors, LLC

Position in ZTS — Zoetis Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in ZTS

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$1,376,555

-$213,054 QoQ

Shares Held

11,645

-7.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $5,648,119 across 52 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (24.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc. This page	11,645	$1,376,555
2	VTRS	Viatris Inc	43,117	$582,510
3	UTHR	UNITED THERAPEUTICS Corp	818	$485,057
4	HIMS	Hims & Hers Health, Inc.	20,825	$432,327
5	NBIX	Neurocrine Biosciences Inc	2,947	$388,237
6	COLL	Collegium Pharmaceutical, Inc	11,677	$386,158
7	TEVA	Teva Pharmaceutical Industries Ltd	11,152	$335,898
8	TAK	Takeda Pharmaceutical Co Ltd	17,828	$330,174

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,376,555	11,645	-7.8%	Shares	Sole	2026-04-07
2025-12-31	$1,589,609	12,634	-8.3%	Shares	Sole	2026-01-23
2025-09-30	$2,017,021	13,785	+15.9%	Shares	Sole	2025-10-14
2025-06-30	$1,855,025	11,895	+151.1%	Shares	Sole	2025-07-11
2025-03-31	$780,111	4,738	+11.1%	Shares	Sole	2025-04-14
2024-12-31	$694,733	4,264	-2.1%	Shares	Sole	2025-02-10
2024-09-30	$851,075	4,356	-24.6%	Shares	Sole	2024-10-29
2024-06-30	$1,000,980	5,774	+103.7%	Shares	Sole	2024-07-31
2024-03-31	$479,710	2,835	+103.5%	Shares	Sole	2024-05-14
2023-12-31	$274,936	1,393	+82.6%	Shares	Sole	2024-02-15
2023-09-30	$132,746	763	+38.0%	Shares	Sole	2023-11-14
2023-06-30	$95,232	553	+3.8%	Shares	Sole	2024-05-14
2023-03-31	$88,712	533	+11.3%	Shares	Sole	2024-05-14
2022-12-31	$70,197	479	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.